Literature DB >> 10674878

Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction.

T Aihara1, Y Fujiwara, M Ooka, I Sakita, Y Tamaki, M Monden.   

Abstract

A novel reverse transcription-polymerase chain reaction (RT-PCR) assay using mammaglobin B gene was developed for detection of breast cancer micrometastases in axillary lymph nodes. Fourteen primary breast cancers and 56 axillary lymph nodes from six patients with primary breast cancer and 15 control lymph nodes from non-cancer bearing patients were subjected to this assay. The transcript of mammaglobin B gene was detected in none of the control lymph nodes, but in all of the 14 primary breast cancers. Eleven out of the 56 lymph nodes from the patients, which were shown to be positive by histological examination, were also proven positive by this assay. On the other hand, fourteen of the 45 (31%) histologically negative lymph nodes were also shown to express mammaglobin B mRNA, which suggested the presence of micrometastases in these lymph nodes. RT-PCR using mammaglobin B gene could therefore be a useful tool for detection of micrometastases of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10674878     DOI: 10.1023/a:1006335817889

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

1.  Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study.

Authors:  V Luyckx; J F Durant; A Camboni; S Gilliaux; C A Amorim; A Van Langendonckt; L M Irenge; J L Gala; J Donnez; M M Dolmans
Journal:  J Assist Reprod Genet       Date:  2013-08-29       Impact factor: 3.412

2.  Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostate.

Authors:  Rebecca Lee Yean Wong; Quan Wang; Lindsey S Treviño; Maarten C Bosland; Jing Chen; Mario Medvedovic; Gail S Prins; Kurunthachalam Kannan; Shuk-Mei Ho; Cheryl Lyn Walker
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

3.  A protein interaction landscape of breast cancer.

Authors:  Minkyu Kim; Jisoo Park; Mehdi Bouhaddou; Kyumin Kim; Ajda Rojc; Maya Modak; Margaret Soucheray; Michael J McGregor; Patrick O'Leary; Denise Wolf; Erica Stevenson; Tzeh Keong Foo; Dominique Mitchell; Kari A Herrington; Denise P Muñoz; Beril Tutuncuoglu; Kuei-Ho Chen; Fan Zheng; Jason F Kreisberg; Morgan E Diolaiti; John D Gordan; Jean-Philippe Coppé; Danielle L Swaney; Bing Xia; Laura van 't Veer; Alan Ashworth; Trey Ideker; Nevan J Krogan
Journal:  Science       Date:  2021-10-01       Impact factor: 63.714

4.  Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.

Authors:  Jiro Okami; Keizo Dono; Masato Sakon; Masanori Tsujie; Nobuyasu Hayashi; Yoshiyuki Fujiwara; Hiroaki Nagano; Koji Umeshita; Shoji Nakamori; Morito Monden
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

Review 5.  Molecular pathology of tumor metastasis. II. Molecular staging and differential diagnosis.

Authors:  József Tímár; Orsolya Csuka; Zsolt Orosz; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

6.  Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

Authors:  S Bellone; R Tassi; M Betti; D English; E Cocco; S Gasparrini; I Bortolomai; J D Black; P Todeschini; C Romani; A Ravaggi; E Bignotti; E Bandiera; L Zanotti; S Pecorelli; L Ardighieri; M Falchetti; C Donzelli; E R Siegel; M Azodi; D-A Silasi; E Ratner; P E Schwartz; T J Rutherford; A D Santin
Journal:  Br J Cancer       Date:  2013-06-27       Impact factor: 7.640

Review 7.  Human mammaglobin in breast cancer: a brief review of its clinical utility.

Authors:  Fawwaz Shakir Al Joudi
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

8.  Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.

Authors:  Renata A Tassi; Stefano Calza; Antonella Ravaggi; Eliana Bignotti; Franco E Odicino; Germana Tognon; Carla Donzelli; Marcella Falchetti; Elisa Rossi; Paola Todeschini; Chiara Romani; Elisabetta Bandiera; Laura Zanotti; Sergio Pecorelli; Alessandro D Santin
Journal:  BMC Cancer       Date:  2009-07-27       Impact factor: 4.430

9.  Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.

Authors:  A Nissan; D Jager; M Roystacher; D Prus; T Peretz; I Eisenberg; H R Freund; M Scanlan; G Ritter; L J Old; S Mitrani-Rosenbaum
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

10.  Quantitative evaluation of metastases in axillary lymph nodes of breast cancer.

Authors:  M Inokuchi; I Ninomiya; K Tsugawa; I Terada; K Miwa
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.